Follow
Ashish Dhir
Ashish Dhir
Memorial Sloan Kettering Cancer Center, New York
Verified email at ucdavis.edu
Title
Cited by
Cited by
Year
Withania somnifera: an Indian ginseng
SK Kulkarni, A Dhir
Progress in neuro-psychopharmacology and biological psychiatry 32 (5), 1093-1105, 2008
5122008
Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
SK Kulkarni, A Dhir
Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2010
4312010
Pentylenetetrazol (PTZ) kindling model of epilepsy
A Dhir
Current protocols in neuroscience 58 (1), 9.37. 1-9.37. 12, 2012
3182012
On the mechanism of antidepressant-like action of berberine chloride
SK Kulkarni, A Dhir
European Journal of Pharmacology 589 (1-3), 163-172, 2008
2592008
Nitric oxide and major depression
A Dhir, SK Kulkarni
Nitric oxide 24 (3), 125-131, 2011
2482011
Potentials of curcumin as an antidepressant
SK Kulkarni, A Dhir, KK Akula
The Scientific World Journal 9, 1233-1241, 2009
2362009
An overview of curcumin in neurological disorders
SK Kulkarni, A Dhir
Indian journal of pharmaceutical sciences 72 (2), 149, 2010
2042010
Natural polyphenols in the management of major depression
L Pathak, Y Agrawal, A Dhir
Expert opinion on investigational drugs 22 (7), 863-880, 2013
1642013
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor
A Dhir, SK Kulkarni
European journal of pharmacology 568 (1-3), 177-185, 2007
1552007
Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride
SK Kulkarni, A Dhir
European journal of pharmacology 569 (1-2), 77-83, 2007
1402007
Effect of various classes of antidepressants in behavioral paradigms of despair
SK Kulkarni, A Dhir
Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (6), 1248-1254, 2007
1392007
Current investigational drugs for major depression
SK Kulkarni, A Dhir
Expert opinion on investigational drugs 18 (6), 767-788, 2009
1232009
Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice
A Dhir, SK Kulkarni
Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (4), 921-925, 2007
1192007
Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action
A Dhir, PS Naidu, SK Kulkarni
Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (8), 1478-1485, 2006
1032006
Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication
M Guignet, K Dhakal, BM Flannery, BA Hobson, D Zolkowska, A Dhir, ...
Neurobiology of disease 133, 104431, 2020
942020
Mechanisms of action of antiseizure drugs
RJ Porter, A Dhir, RL Macdonald, MA Rogawski
Handbook of clinical neurology 108, 663-681, 2012
932012
Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: Possible involvement of GABAergic system
SK Kulkarni, KK Akula, A Dhir
CSIR, 2008
892008
Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: Possible involvement of GABAergic system
SK Kulkarni, KK Akula, A Dhir
CSIR, 2008
892008
Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice
A Dhir, PS Naidu, SK Kulkarni
Seizure 16 (8), 691-697, 2007
872007
Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice
A Dhir, SSV Padi, PS Naidu, SK Kulkarni
European journal of pharmacology 535 (1-3), 192-198, 2006
832006
The system can't perform the operation now. Try again later.
Articles 1–20